News | November 25, 2021
ADB approves US $ 1.5 bn for Covid-19 vaccines in India
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The company will provide the technical and financial resources to support the study
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
Since its inception, the company has either acquired or taken a majority stake in five companies
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Subscribe To Our Newsletter & Stay Updated
